GB0128287D0 - Novel method and compounds - Google Patents

Novel method and compounds

Info

Publication number
GB0128287D0
GB0128287D0 GBGB0128287.0A GB0128287A GB0128287D0 GB 0128287 D0 GB0128287 D0 GB 0128287D0 GB 0128287 A GB0128287 A GB 0128287A GB 0128287 D0 GB0128287 D0 GB 0128287D0
Authority
GB
United Kingdom
Prior art keywords
compounds
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0128287.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0128287.0A priority Critical patent/GB0128287D0/en
Publication of GB0128287D0 publication Critical patent/GB0128287D0/en
Priority to AU2002352142A priority patent/AU2002352142A1/en
Priority to PCT/EP2002/013261 priority patent/WO2003045949A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0128287.0A 2001-11-26 2001-11-26 Novel method and compounds Ceased GB0128287D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0128287.0A GB0128287D0 (en) 2001-11-26 2001-11-26 Novel method and compounds
AU2002352142A AU2002352142A1 (en) 2001-11-26 2002-11-25 Pyrazolopyridine derivatives
PCT/EP2002/013261 WO2003045949A1 (en) 2001-11-26 2002-11-25 Pyrazolopyridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0128287.0A GB0128287D0 (en) 2001-11-26 2001-11-26 Novel method and compounds

Publications (1)

Publication Number Publication Date
GB0128287D0 true GB0128287D0 (en) 2002-01-16

Family

ID=9926458

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0128287.0A Ceased GB0128287D0 (en) 2001-11-26 2001-11-26 Novel method and compounds

Country Status (3)

Country Link
AU (1) AU2002352142A1 (en)
GB (1) GB0128287D0 (en)
WO (1) WO2003045949A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851247B1 (en) 2003-02-19 2007-06-29 Exonhit Therapeutics Sa METHODS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DEGENERATIVE PATHOLOGIES
ES2305776T3 (en) 2003-06-17 2008-11-01 Pfizer Inc. DERIVATIVES OF N-PIRROLIDIN-3-IL-AMIDA AS INHIBITORS OF THE RE-CAPTURE OF SEROTONINE AND NORADRENALINE.
BRPI0411891A (en) 2003-06-27 2006-08-29 Pfizer Prod Inc pyrazol [3,4-b] pyridin-6-ones as gsk-3 inhibitors
ES2308186T3 (en) * 2003-06-27 2008-12-01 Pfizer Products Inc. PIRAZOLO (3,4-B) PIRIDIN-6-ONAS AS INHIBITORS OF GSK-3.
FR2856595B1 (en) * 2003-06-27 2008-05-30 Exonhit Therapeutics Sa METHODS AND COMPOSITIONS FOR TREATING COGNITIVE DEFICITS.
US7626021B2 (en) 2004-07-27 2009-12-01 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
US7361764B2 (en) 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
EP1781654A1 (en) 2004-07-27 2007-05-09 SGX Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
AU2005269387A1 (en) 2004-07-27 2006-02-09 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
US7709645B2 (en) 2004-07-27 2010-05-04 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
PE20061119A1 (en) * 2005-01-19 2006-11-27 Aventis Pharma Sa PYRAZOLO PYRIDINES SUBSTITUTED AS INHIBITORS OF FAK, KDR AND Tie KINASES
FR2888579A1 (en) * 2005-07-13 2007-01-19 Aventis Pharma Sa New pyrazole substituted pyridine compounds are kinase inhibitors, useful as an inhibiting agent for kinase-catalyzed reaction and for the manufacture of a drug to treat cancer
WO2006130673A1 (en) 2005-05-31 2006-12-07 Janssen Pharmaceutica, N.V. 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
FR2889526B1 (en) 2005-08-04 2012-02-17 Aventis Pharma Sa SUBSTITUTED 7-AZA-INDAZOLES, COMPOSITIONS CONTAINING SAME, PROCESS FOR PRODUCTION AND USE
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
JP2009513672A (en) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド GABA receptor-mediated regulation of neurogenesis
US8017781B2 (en) 2005-11-15 2011-09-13 Vertex Pharmaceuticals Incorporated Azaindazoles useful as inhibitors of kinases
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
ES2587014T3 (en) * 2006-11-24 2016-10-20 Ac Immune S.A. N- (methyl) -pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid proteins
BRPI0810496A2 (en) * 2007-04-09 2018-11-06 Hoffmann La Roche non-nucleoside reverse transcriptase inhibitors
KR20090031122A (en) * 2007-09-21 2009-03-25 주식회사 중외제약 Compounds containing indazole frameworks, preparing method thereof and pharmaceutical composition containing thereof
AU2008331733A1 (en) 2007-11-02 2009-06-11 Vertex Pharmaceuticals Incorporated [1H- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2311823A1 (en) 2009-10-15 2011-04-20 AC Immune S.A. 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
KR20120063283A (en) * 2010-12-07 2012-06-15 제일약품주식회사 Novel pyrazolopyridine derivatives or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same
US8791112B2 (en) * 2011-03-30 2014-07-29 Arrien Pharmaceuticals Llc Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
WO2016004272A1 (en) 2014-07-02 2016-01-07 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase
EP3920885A1 (en) 2019-02-08 2021-12-15 Frequency Therapeutics, Inc. Valproic acid compounds and wnt agonists for treating ear disorders
KR102580387B1 (en) * 2021-05-07 2023-09-19 한국화학연구원 Pharmaceutical compositions comprising novel pyrazolo[3,4-b]pyridine derivatives for preventing or treating metabolic diseases including obesity and diabetes mellitus, or nonalcholic steatohepatitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL106896B1 (en) * 1978-01-03 1980-01-31 METHOD OF MAKING NEW BIOLOGICALLY ACTIVE PYRAZOLO- / 3,4-B / -pyridine DERIVATIVES
CZ287613B6 (en) * 1994-06-16 2001-01-17 Pfizer Pyrazolo- and pyrrolopyridines and pharmaceutical preparations based thereon
AU2001287898A1 (en) * 2000-09-22 2002-04-02 Stephen Garland Pyrazolopyridines and pyrazolopyridazines as antidiabetics

Also Published As

Publication number Publication date
WO2003045949A1 (en) 2003-06-05
AU2002352142A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
GB0128287D0 (en) Novel method and compounds
GB0109993D0 (en) Method
GB0118251D0 (en) Method
EP1434772A4 (en) Compounds and methods
GB0122049D0 (en) Method
GB0115243D0 (en) Method
GB0109049D0 (en) Method
AU2002359694A8 (en) Compounds and methods
GB0103998D0 (en) Method
GB0116453D0 (en) Method
GB0114629D0 (en) Method
GB0126531D0 (en) Method
EP1379240A4 (en) Compounds and methods
GB0101762D0 (en) Method
GB0110547D0 (en) Method
GB0108349D0 (en) Method
GB0116142D0 (en) Method
GB0101763D0 (en) Method
GB0102947D0 (en) Method
GB0119009D0 (en) Compound and process
GB0111987D0 (en) Method
GB0125793D0 (en) Method
GB0119339D0 (en) Method
GB0108975D0 (en) Novel method and compounds
GB0111206D0 (en) Novel method and compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)